"Abbott Suffers From Humira Slowdown"

http://www.fiercepharma.com/story/abbott-suffers-humira-slowdown/2009-04-16?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FP0

From the article:
"Abbott Laboratories may have increased first-quarter profits by more than 50 percent, but those numbers came with two caveats: One, about half of the the profits leap is due to a one-time, 7 million gain on the wrap-up of a partnership with Takeda Pharmaceutical (plus other items). Two, Abbott's top-selling Humira is facing a decline in demand as newly cost-conscious patients back away from the pricey anti-inflammatory. And that doesn't bode well for the rest of 2009."

Depressing that people have to make that choice. Also depressing they called it a "pricey anti-inflammatory"!!!!!! That's not really accurate, is it? Pricey, yes.

The battle against "ignorance" is not just annoying anymore. If people think that Humira is just a "pricey anti-inflammatory," no wonder they think it's ok to forego their injections and just substitute a different (cheaper) anti-inflammatory.

As uncomfortable as it can be, we must all educate constantly. ~Kelly Young difficulties with my ISP today and cannot get the link to open. I wonder if the author of the article thinks RA is just a few aches and pains?! It seems to be an article targeted to business/investor types - as is typical, they have to dumb down the science until it makes almost no sense in order to compensate for the rampant scientific illiteracy that is so rampant in our culture. [QUOTE=Spelunker]

Hi Suzanne, I am having some _{(cough, cough)} difficulties with my ISP today and cannot get the link to open. I wonder if the author of the article thinks RA is just a few aches and pains?! [/QUOTE]

Here is a link to Bloomberg from the original article, looks like she was just saying what they said?:

http://www.bloomberg.com/apps/news?pid=20601202&sid=ak9g_hmDZjbE&refer=healthcare

There was also a link to WSJ, but you only get a preview unless you subscribe (they also call it an anti-inflamm.). You can see the comments, though - one mom whose daughter uses Humira made a comment:

http://online.wsj.com/article/SB123979282982320553.html
[QUOTE=JasmineRain]It seems to be an article targeted to business/investor types - as is typical, they have to dumb down the science until it makes almost no sense in order to compensate for the rampant scientific illiteracy that is so rampant in our culture. [/QUOTE]

Thanks JamineRain, I was able to access the link(s) this mid-morning and I concur with you assessment. Investors are, at least in my experience, much more interested in the bottom line than is medical results-science be damned.
[QUOTE=Spelunker] [QUOTE=JasmineRain]It seems to be an article targeted to business/investor types - as is typical, they have to dumb down the science until it makes almost no sense in order to compensate for the rampant scientific illiteracy that is so rampant in our culture. [/QUOTE]

Thanks JamineRain, I was able to access the link(s) this mid-morning and I concur with you assessment. Investors are, at least in my experience, much more interested in the bottom line than is medical results-science be damned.
[/QUOTE]

I would think Abbott would want to set the record straight, regardless. I checked both the Bloomberg and WSJ links, and didn't see any corrections or comments with a clarification yet. Maybe after the weekend. They should protect their brand, I think, no matter who the audience is.
Interesting post. [QUOTE=Jan Lucinda]Interesting post.[/QUOTE]

itneresting how someone so retarded can actually use a keyboard
[QUOTE=Jan Lucinda]Interesting post.[/QUOTE]

OBVIOUSLY... you don't even comprehend what the post is about!!

[QUOTE=babs10][QUOTE=Jan Lucinda]Interesting post.[/QUOTE]
Copyright ArthritisInsight.com

"Abbott Suffers From Humira Slowdown" | Arthritis Information